Vivotif

Vivotif is an oral typhoid vaccine containing the live, attenuated Salmonella Typhi strain Ty21a. It helps protect against typhoid fever caused by Salmonella Typhi bacteria. Suitable for adults and children aged 6 years and older. Recommended for travelers to high-risk regions.

Vivotif is used to prevent typhoid fever, a serious bacterial infection spread through contaminated food and water. It is commonly recommended for travelers visiting areas where typhoid is prevalent, as well as for household contacts of typhoid carriers. The vaccine works by stimulating the body's immune response to the bacteria.

After taking Vivotif, some individuals may experience mild effects such as stomach discomfort, nausea, or headache. These effects are generally temporary and resolve on their own. The vaccine does not cause typhoid fever, as the bacteria used are weakened and unable to cause illness.

Vivotif should be stored in a refrigerator and protected from light. It is important to complete the full vaccination course as directed by a healthcare provider. Individuals with weakened immune systems or severe illnesses should consult a doctor before use. Keep the vaccine out of reach of children.

Vivotif may interact with certain medications, including antibiotics and immunosuppressants. Avoid taking antibiotics for at least 24 hours before and after vaccination, as they may reduce effectiveness. Consult a healthcare provider if you are on any long-term medications or have recently received other vaccines.